Bank of America’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$293K Sell
41,392
-2,752
-6% -$19.4K ﹤0.01% 5168
2025
Q4
$219K Buy
44,144
+21,687
+97% +$91.4K ﹤0.01% 5299
2025
Q3
$101K Buy
22,457
+21,677
+2,779% +$73.8K ﹤0.01% 6587
2025
Q2
$2.43K Hold
780
﹤0.01% 7405
2025
Q1
$1.96K Hold
780
﹤0.01% 7338
2024
Q4
$2.42K Hold
780
﹤0.01% 7183
2024
Q3
$1.86K Hold
780
﹤0.01% 7139
2024
Q2
$1.97K Hold
780
﹤0.01% 7144
2024
Q1
$2.3K Sell
780
-79
-9% -$243 ﹤0.01% 7110
2023
Q4
$2.59K Buy
859
+79
+10% +$254 ﹤0.01% 7103
2023
Q3
$2.96K Hold
780
﹤0.01% 7097
2023
Q2
$3.41K Hold
780
﹤0.01% 7059
2023
Q1
$2.24K Buy
780
+770
+7,700% +$2.69K ﹤0.01% 7202
2022
Q4
$32 Hold
10
﹤0.01% 7886
2022
Q3
$0 Hold
10
﹤0.01% 7920
2022
Q2
$0 Hold
10
﹤0.01% 8096
2022
Q1
$0 Buy
+10
New +$118 ﹤0.01% 8358

Other funds holding DRTS

Bank of America's DRTS Position: Q1 2026 in Review

Bank of America reduced its Alpha Tau Medical (DRTS) stake by 6.2% in Q1 2026, selling an estimated $19.4K and leaving 41,392 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #5168.

Bank of America first reported a position in DRTS in Q1 2022 and has held it in 17 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Bank of America held 41,392 shares of Alpha Tau Medical worth $293K as of Q1 2026.
  • Bank of America sold 2,752 Alpha Tau Medical shares in Q1 2026, an estimated $19.4K.
  • Alpha Tau Medical made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5168 holding.
  • Bank of America first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 17 quarters since.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.